Skip to main content
Journal of Orthopaedics and Traumatology

Official Journal of the Italian Society of Orthopaedics and Traumatology

Download PDF
  • Original article
  • Open access
  • Published:

The necessity of routine postoperative laboratory tests after total hip arthroplasty for hip fracture in a semi-urgent clinical setting

Journal of Orthopaedics and Traumatology volume 21, Article number: 19 (2020) Cite this article

Abstract

Background

Recent studies suggest that routine postoperative laboratory tests are not necessary after primary elective total hip arthroplasty (THA). This study aims to evaluate the utility of routine postoperative laboratory tests in patients undergoing THA for hip fracture in a semi-urgent clinical setting.

Materials and methods

This retrospective study included 213 consecutive patients who underwent primary unilateral THA for hip fractures. Patient demographics, clinical information, and laboratory tests were obtained from the electronic medical record system. Multivariate logistic regression analysis was performed to identify risk factors associated with abnormal laboratory test-related interventions.

Results

A total of 207 patients (97.18%) had abnormal postoperative laboratory results, which were mainly due to anemia (190/213, 89.20%) and hypoalbuminemia (154/213, 72.30%). Overall, 54 patients (25.35%) underwent a clinical intervention, 18 patients received blood transfusion, and 42 patients received albumin supplementation. Factors associated with blood transfusion were long operative time and low preoperative hemoglobin levels. Factors associated with albumin supplementation were long operative time and low preoperative albumin levels. Of the 33 patients with abnormal postoperative creatinine levels, 7 patients underwent a clinical intervention. For electrolyte abnormalities, sodium supplementation was not given for hyponatremia, three patients received potassium supplementation, and one patient received calcium supplementation.

Conclusions

This study demonstrated a high incidence of abnormal postoperative laboratory tests and a significant clinical intervention rate in patients who underwent THA for hip fracture in a semi-urgent clinical setting, which indicates that routine laboratory tests after THA for hip fracture are still necessary for patients with certain risk factors.

Level of Evidence

Level III.

Trial registration Clinical trial registry number ChiCTR1900020690.

Introduction

Along with the rapid aging of the global population, hip fractures continue to be a global concern. Hip fractures affect more than 2 million people annually, and this number is modestly projected to increase to 6.26 million worldwide by 2050 [1,2,3]. The appropriate timing of hip fracture surgery has long been debated and studied extensively, and the current guidelines indicate that surgery for hip fracture should be performed within 48 h after injury for favorable outcomes [4,5,6,7,8,9,10]. However, surgical procedures often need to be delayed in clinical practice. Notably, total hip arthroplasty (THA) for hip fracture continues to grow as a treatment choice, as evidenced by trends in data from the USA, and a recent study indicated that the time to surgery does not affect mortality, revision for any reason, or the implant failure rate in patients undergoing THA [11, 12]. Compared with patients who underwent primary elective non-hip fracture THA, patients who underwent THA for hip fracture represent a high-risk group with concomitant medical comorbidities [13,14,15,16,17,18]. As a regional tertiary referral center, plenty of frail elderly patients with hip fracture and multiple comorbidities are transferred to our department. The majority of these patients are medically complex and surgery is usually postponed to allow for detailed medical evaluations to ensure that patients’ conditions are stable, and for preoperative correction (e.g., anemia, hypoalbuminemia) and medical optimization (e.g., pulmonary reserve, nutrition). Therefore, THA for hip fracture is treated as a semi-elective surgery in our routine clinical practice.

Several studies have recently evaluated the necessity of routine postoperative laboratory tests after primary elective total joint arthroplasty (TJA) [19,20,21,22,23,24,25,26,27]. These studies suggested that routine postoperative laboratory tests are not necessary for modern-day primary unilateral TJA, and only patients with specific risk factors should undergo postoperative laboratory tests [19,20,21,22,23,24,25,26,27]. The objective of this retrospective study is to assess the utility of routine postoperative laboratory tests after THA for hip fracture, after preoperative optimization in a semi-urgent clinical setting. We hypothesize that routine postoperative laboratory tests are unnecessary after THA in relatively healthy patients with hip fracture but may still be necessary for hip fracture patients with severe medical comorbidities.

Materials and methods

Ethical approval for this study was obtained from our institutional ethical committee. This study complied with the Declaration of Helsinki and was approved by our institutional review board. The study protocol was registered in the International Clinical Trials Registry Platform (Registry Number: ChiCTR1900020690) [28].

Study design and population

For this retrospective analysis, we included consecutively treated patients who underwent primary unilateral THA for hip fractures between January 2016 and November 2018 at a single institution. Adult patients who suffered from femoral neck fracture or intertrochanteric fracture and underwent primary unilateral THA were screened for potential eligibility. The exclusion criteria were as follows: (1) having undergone hemiarthroplasty, (2) having undergone THA for failed fixation of hip fractures, (3) having undergone THA for pathologic hip fractures or pathologic fractures around the hip, (4) having a history of a bleeding disorder, and (5) operative times over 240 min or less than 20 min (to limit the influence of extreme outliers) [28].

Data collection

Demographic data and data related to the surgery and laboratory tests were retrieved from the electronic medical record system and entered in a standardized form (Excel 2019, Microsoft Corporation, Redmond, WA, USA). The following information was collected for each eligible patient: age, sex, body mass index (BMI), preoperative comorbidities, American Society of Anesthesiologists (ASA) physical status classification, operative time (defined as the time from the skin incision to wound closure), intraoperative blood loss, use of tranexamic acid (TXA), length of hospital stay, preoperative and postoperative laboratory test results [complete blood count (CBC) and comprehensive metabolic panel (CMP)], and any medical intervention directly related to abnormal laboratory test results.

Study outcomes

The predefined outcomes included any medical interventions administered in response to abnormal postoperative laboratory test results, such as anemia prompting blood transfusion, hypoalbuminemia prompting albumin supplementation, and electrolyte disturbances requiring correction, hospitalist/specialist consultations, the initiation or discontinuation of medication, or additional scheduled laboratory tests.

Perioperative management

In our institution, hip fracture patients who are admitted for THA routinely undergo extensive medical evaluations to determine their clinical status and ensure that their conditions are sufficiently stable to tolerate surgery. Usually, some patients with hip fractures have one or more chronic comorbidities or physiologic decompensation, and some of them require medical correction prior to surgery. In our clinical practice, patients who presented with preoperative anemia are usually treated with recombinant human erythropoietin (rHuEPO) and intravenous iron, unless they meet the criterion for blood transfusion [hemoglobin (Hb) level of < 70 g/L or symptomatic anemia with a Hb level > 70 g/L]. Based on our enhanced recovery after surgery (ERAS) protocol, a doctor from the Department of Nutrition is responsible for assessing patients’ nutritional status and preparing small-peptide and whole-protein formulas, which are orally administered perioperatively to improve patients’ nutritional status and correct hypoalbuminemia. Albumin supplementation is also not routinely given to patients with preoperative hypoalbuminemia (30 ≤ albumin concentration < 35 g/L), unless they meet the criterion for albumin supplementation (albumin concentration < 30 g/L). For preoperative electrolyte disturbances, patients with mild or moderate abnormalities usually receive orally administered mediation (food or tablet), and only patients with severe depletion receive electrolyte supplementation (Additional file 1: Material 1) [28,29,30,31]. If patients received a blood transfusion or albumin supplementation before surgery, a retest after transfusion was mandatory to assess the response and guide whether further transfusions are required, and the preoperative retest results would be used for data analysis.

Of note, in the operating room and postanesthesia care unit (PACU), blood gas analysis was performed on arterial blood samples, the results of which were also used to guide fluid and electrolyte supplement management [28].

Statistical analysis

For quantitative data, the mean ± standard deviation (SD) or median (interquartile range) was calculated, and comparisons between groups were performed using the t-test or Wilcoxon rank-sum test, as appropriate. For qualitative data, the frequency or percentage was calculated, and group comparisons were performed using the chi-square test or Fisher’s exact test. Multivariate regression models were generated to identify variables that had the strongest associations with abnormal postoperative laboratory tests necessitating a medical intervention, and only candidate variables with a P value of not more than 0.1 in the univariate analysis were included in a multivariate model. The results are presented using the odds ratio (OR) with 95% confidence interval (CI). P < 0.05 was considered statistically significant (two-tailed). All statistical analyses were performed using SPSS, version 21.0 software (SPSS Inc., Chicago, IL, USA).

Results

Patient characteristics

Of the 690 potentially eligible patients, a total of 213 hip fracture patients were identified, including 155 (72.77%) female and 58 (27.23%) male patients. Of the included patients, 158 (74.18%) patients received uncemented THA and 55 (25.82%) patients received hybrid THA. The patient demographics and perioperative data are presented in Table 1. The incidences of preoperative anemia and hypoalbuminemia were 41.78% (89/213) and 10.33% (22/213), respectively, in the preoperative period (Table 2). However, after surgery, 207 patients (97.18%) had abnormal postoperative laboratory results, which were mainly due to anemia (190/213, 89.20%) and hypoalbuminemia (154/213, 72.30%). Overall, 54 patients (25.35%) with abnormal postoperative laboratory test results necessitated clinical intervention (Tables 3 and 4).

Table 1 Baseline characteristics of the study cohorts
Full size table
Table 2 Abnormal preoperative laboratory tests in different patient groups
Full size table
Table 3 Comparison of variables between patients with abnormal postoperative laboratory tests and with or without intervention
Full size table
Table 4 Abnormal postoperative laboratory tests and intervention directly related to abnormal laboratory tests in the study cohorts
Full size table

Hb

Of the 190 patients with postoperative anemia, 18 patients received blood transfusions, and they were compared with those who did not require blood transfusion. The univariate analysis detected significant differences between the two groups of patients in the ASA score, operative time, and preoperative Hb level. Multivariate logistic regression analysis showed that long operative time (OR 1.018, 95% CI 1.003–1.033, P = 0.015) and low preoperative Hb levels (OR 0.950, 95% CI 0.913–0.989, P = 0.012) were independent risk factors for postoperative blood transfusion (Additional file 2: Material S2).

Albumin

For abnormal postoperative albumin levels, univariate analysis showed that age, BMI, ASA score, operative time, and preoperative albumin levels were associated with postoperative albumin supplementation. Multivariate logistic regression revealed that long operative time (OR 1.013, 95% CI 1.001–1.024, P = 0.035) and low preoperative albumin level (OR 0.757, 95% CI 0.673–0.852, P < 0.001) were independent risk factors for postoperative albumin supplementation.

Creatinine

Although 33 (15.49%) patients had abnormal postoperative creatinine levels, most of whom were asymptomatic with no adverse events, only 1 patient undergoing regular hemodialysis treatment required additional dialysis. One patient was administered a fluid bolus, two patients were administered NiaoDuQing granules (a traditional Chinese medicine) after consultation, and three patients underwent clinical observation only after consultation.

Electrolyte disturbances

Hyponatremia was responsible for all Na abnormalities, but Na supplementation was not administered. Regarding K abnormalities, five patients had mild hypokalemia (3.0–3.5 mmol/L), three of whom received K supplementation, five patients had mild hyperkalemia (5.4–6.0 mmol/L), all of whom did not receive any treatment, and one patient had moderate hyperkalemia (6.0–6.4 mmol/L) and required an additional hemodialysis treatment as described previously. A total of 116 (54.46%) patients had postoperative hypocalcemia, but only 1 patient received postoperative calcium supplementation, one patient with mild hypercalcemia received no treatment. Multiple logistic regression analysis could not be performed due to the very low intervention rates for abnormal postoperative creatinine, Na, K, and Ca levels (Additional file 3: Material S3).

Discussion

Main findings

To the best of the authors’ knowledge, this study represents the first attempt to evaluate the utility of routine postoperative laboratory tests after THA for hip fracture in a semi-urgent clinical setting. In this study, a high incidence of abnormal postoperative laboratory test results and a substantial intervention rate after THA for hip fracture patients were noted in the included patients, and risk factors for blood transfusion and albumin supplementation were identified. The findings suggest that routine postoperative laboratory tests for certain patients with risk factors are justifiable.

Comparison with previous studies

Recently, several studies on this topic have been published; however, the results of this study conflict with those of previous similar studies [24, 26, 27]. In contrast, previous research mainly focused on primary elective THA patients, which are significantly different from hip fracture patients who undergo semi-elective THA. In general, patients undergoing THA for acute hip fractures are at a substantially higher risk of medical comorbidities and complications than patients undergoing primary elective THA [18, 31,32,33,34]. Compared with non-hip fracture patients, hip fracture patients represent a high-risk population with older age, female predominance, lower BMI, poorer nutritional status, more concomitant medical comorbidities, and more preoperative abnormalities (Table 5). These differences accounted for most of the differences in the outcomes between the two subpopulations.

Table 5 Comparison of patient characteristics with previous similar studies
Full size table

Although patient characteristics may explain the high incidence rates of abnormal postoperative laboratory tests and clinical intervention, the perioperative clinical pathway and physiological processes associated with hip fracture (e.g., the acute inflammatory stress, catabolic states) may also account for some of the high incidences [18, 35, 36]. The clinical pathway for THA differs between non-hip patients and hip fracture patients and can vary among institutions, which may lead to diverse results.

Implications for clinical practice

Although clinical guidelines recommend surgical treatment within 48 h after hip fracture, in clinical practice, hip fracture surgery is often postponed for potential benefits from preoperative optimization, but also maybe due to the limited capacity of operating rooms or personnel [37]. This delay in processes may partially account for some of the perioperative morbidity and abnormal postoperative laboratory tests; therefore, these may represent modifiable risk factors. Even though hip fracture patients tend to have more preoperative abnormalities and a higher burden of comorbidities than non-hip patients, preoperative medical stabilization and optimization are often not associated with relevant interventions, as most of the abnormal preoperative laboratory test results do not meet the criteria for clinical interventions. As hip fracture surgery should be performed early to minimize exposure to the intrinsic harmful factors of fracture, relevant treatment interventions should be implemented promptly to improve the clinical state of patients. Additional studies are still warranted to balance the benefits and risks of early surgery for mobilization and delayed surgery for preoperative optimization.

The operative time was found to be an independent predictor for blood transfusion and albumin supplementation, and it is a readily available measure that can aid in risk stratification and decision-making regarding postoperative laboratory test results [38,39,40]. In effect, although THA involves many standardized surgical procedures and cannot be unnecessarily shortened, many avoidable factors can introduce intraoperative delay, which includes but not limited to the surgeons’ experience (e.g., surgical resident, senior surgeon, and consultant), preoperative planning, timing of the surgery (e.g., nights, weekends, or holidays), and compatibility of the multidisciplinary team [41]. Therefore, surgeon training and experience, preoperative planning, and procedure efficiency should be optimized to minimize the operative time.

THA is characterized by significant blood loss, and blood transfusions have always been inevitable, especially among hip fracture patients. The transfusion rate was once as high as 30–70%, but has fallen precipitously since the 2010s; it is as low as 9% for THA [42,43,44,45,46]. Blood conservation strategies, including new surgical techniques, Hb optimization, induced hypotension, and in particular, application of TXA, have fundamentally changed perioperative blood management [18, 23,24,25, 28, 47]. Therefore, the incidences of postoperative anemia and related transfusion were much lower than they were before, and the values of postoperative CBC became reasonably limited. Our study found that the transfusion rate was 8.45%, and the risk factors for transfusion were long operative time and low preoperative Hb levels.

It is noticeable, however, that hypoalbuminemia presents another severe challenge of THA for hip fracture patients. Hypoalbuminemia is not synonymous with malnutrition or undernutrition, but is highly related to it. Hypoalbuminemia has been associated with increased perioperative morbidity and mortality, and in general, cardiac, as well as orthopedic surgery [48,49,50,51,52]. In our study, 72.30% of the patients developed hypoalbuminemia after THA, and 19.72% of the patients met the criteria and received albumin supplementation. We detected that long operative time and low preoperative albumin levels were independent risk factors for postoperative albumin supplementation. As diet plays an important role in nutrition status, multimodel nutritional management, especially perioperative oral nutritional supplementation, would improve the level of serum albumin, and albumin infusion remains essential and beneficial for patients with malnutrition or undernutrition [53, 54].

Previous research has fully expounded that chronic kidney disease (CKD) is a significant risk factor for abnormal postoperative creatinine levels and acute kidney injury (AKI) [22, 55, 56]. For patients with definitive preoperative diagnosis of CKD, preoperative assessment of renal function remains essential, and nephrotoxic agents should be reduced or avoided to prevent induced AKI [22]. In the present study, most abnormal patients experienced flare-ups of the creatinine level without clinical symptoms or related complications.

Mild forms of electrolyte disturbance may not cause any symptoms and often go undetected until they are discovered during a routine basic metabolic panel (BMP) test. Nevertheless, clinical symptoms usually start to appear once the severity of a particular disorder has increased. Currently, information on the prognosis of patients with hyponatremia who have undergone THA is limited, and the vast majority of patients neither have any symptoms nor receive any interventions. Previous studies have indicated that the baseline Na levels, age, and not using TXA are significant outcome predictors [22,23,24]. The incidences of abnormal Na level (10.80% versus 41.3%) and intervention rate (0% versus 14.5%) were significantly lower in our study than in a previous study, which may mainly be attributed to differences in postoperative intravenous infusion and the common use of normal saline as an infusion solution [22].

For abnormal serum K levels, symptoms of hypokalemia or hyperkalemia, such as cardiac arrhythmias, have been fully described. Clinical interventions related to hypokalemia or hyperkalemia tend to be more aggressive, and no patient presented with atypical symptoms or reported discomfort. Previous studies have indicated that abnormal baseline K values, anemia, female sex, diabetes, and CKD are risk factors for abnormal postoperative K values [22,23,24, 26]. The incidence of abnormal K levels (5.16% versus 25.2%) and intervention rate (1.41% versus 32.6%) were also significantly lower in our study, which may mainly be attributed to differences in intraoperative fluid management and the correction of electrolyte disturbance [22, 28].

Regarding abnormal serum calcium levels, postoperative hypocalcemia might trigger cardiac arrhythmia events and induce blood coagulation dysfunction. Although hypocalcemia frequently occurs after THA (54.93%), clinical symptoms associated with hypocalcemia are extremely rare [57]. Routinely, no intervention would be applied for hypocalcemia, but there is a limited understanding of hypocalcemia in patients after THA, thus warranting additional studies [58].

Strengths and limitations

A major strength of this study is that it represents the first investigation of the necessity of routine postoperative laboratory tests after THA for hip fracture in a semi-urgent clinical setting. This study also had several limitations that affected the interpretation of the results, beginning with the retrospective nature of the study design. The small number of patients included from a single tertiary academic center, particularly in a semi-urgent clinical setting, may limit the generalizability of these findings. Next, the clinical management of patients in response to postoperative laboratory abnormalities may vary among surgeons, and decisions to adopt interventions were made to some extent based on the clinical judgment of each surgeon. In addition, other data (e.g., comorbidities and related medications) and events (e.g., perioperative complications) were not collected from the electronic medical record system, thereby limiting additional analyses. Last, follow-up data, including consultations, complications, and mortality rates were not available.

Conclusions

This study showed a high occurrence of abnormal postoperative laboratory tests and a significant clinical intervention rate, which provides evidence that the routine practice of obtaining postoperative laboratory tests after THA for hip fracture is still necessary for certain patients. Long operative time and low preoperative Hb levels increase the risk of blood transfusion, whereas long operative time and low preoperative albumin levels increase the risk of albumin supplementation. However, the majority of abnormalities are inconsequential.

Grant disclosures

This study received no specific grant from any funding agency, commercial, or not-for-profit sectors.

Availability of data and materials

The datasets used and analyzed during the study are available from the corresponding author on reasonable request.

Abbreviations

AKI:

Acute kidney injury

ASA:

American Society of Anesthesiologists Physical Status Classification

BMI:

Body mass index

BPM:

Basic metabolic panel

CI:

Confidence interval

CKD:

Chronic kidney disease

CMP:

Comprehensive metabolic panel

ERAS:

Enhanced recovery after surgery

F:

Female

Hb:

Hemoglobin

LOS:

Length of stay

M:

Male

N:

Number

OR:

Odds ratio

PACU:

Postanesthesia care unit

rHuEPO:

Recombinant human erythropoietin

SD:

Standard deviation

THA:

Total hip arthroplasty

TJA:

Total joint arthroplasty

TXA:

Tranexamic acid

U.S.:

United States

References

  1. Johansen A, Golding D, Brent L, Close J, Gjertsen J-E, Holt G, Hommel A, Pedersen AB, Röck ND, Thorngren K-G (2017) Using national hip fracture registries and audit databases to develop an international perspective. Injury 48(10):2174–2179

    Article  PubMed  Google Scholar 

  2. Cooper C, Campion G, Lr M (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2(6):285–289

    Article  CAS  PubMed  Google Scholar 

  3. Johansen A, Parker M (2006) Hip fracture. BMJ 333:27–30

    Article  PubMed  PubMed Central  Google Scholar 

  4. Varady NH, Ameen BT, Chen AF (2020) Is delayed time to surgery associated with increased short-term complications in patients with pathologic hip fractures? Clin Orthop Relat Res 478(3):607–615

    Article  PubMed  Google Scholar 

  5. Klestil T, Röder C, Stotter C, Winkler B, Nehrer S, Lutz M, Klerings I, Wagner G, Gartlehner G, Nussbaumer-Streit B (2018) Impact of timing of surgery in elderly hip fracture patients: a systematic review and meta-analysis. Sci Rep 8(1):1–15

    Article  CAS  Google Scholar 

  6. Pincus D, Ravi B, Wasserstein D, Huang A, Paterson JM, Nathens AB, Kreder HJ, Jenkinson RJ, Wodchis WP (2017) Association between wait time and 30–day mortality in adults undergoing hip fracture surgery. JAMA 318(20):1994–2003

    Article  PubMed  PubMed Central  Google Scholar 

  7. AAOS American Academy of Orthopaedic Surgeons. Management of Hip Fractures in The Elderly: Timing of Surgical Intervention. https://aaos.org/globalassets/quality-and-practice-resources/hip-fractures-in-the-elderly/hip-fx-timing-measure-technical-report.pdf.

  8. National Clinical Guideline Centre, (2011) [The Management of Hip Fracture in Adults]. London: National Clinical Guideline Centre. https://www.nice.org.uk/guidance/cg124.

  9. TQIP A. Best practices in the management of orthopaedic trauma. ACS TQIP Best Practices in Management of Orthopaedic Trauma. 2015; https://www.facs.org/quality-programs/trauma/tqp/center-programs/tqip/best-practice.

  10. Canadian Institute for Health Information. Wait Times for Priority Procedures in Canada, 2018: Technical Notes. Ottawa, ON: CIHI; 2018. https://secure.cihi.ca/free_products/wt2018-tech-notes-2018-en-web.pdf.

  11. Ju DG, Rajaee SS, Mirocha J, Lin CA, Moon CN (2017) Nationwide analysis of femoral neck fractures in elderly patients: a receding tide. J Bone Joint Surg Am 99(22):1932–1940

    Article  PubMed  Google Scholar 

  12. Müller F, Galler M, Zellner M, Bäuml C, Grechenig S, Kottmann T, Füchtmeier B (2019) Total hip arthroplasty for hip fractures: time to surgery with respect to surgical revision, failure, and mortality. Geriatr Orthop Surg Rehabil 10:2151459318818162

    Article  PubMed  PubMed Central  Google Scholar 

  13. Schroer WC, Diesfeld PJ, LeMarr AR, Morton DJ, Reedy ME (2018) Hip fracture does not belong in the elective arthroplasty bundle: presentation, outcomes, and service utilization differ in fracture arthroplasty care. J Arthroplasty 33(7):S56–S60

    Article  PubMed  Google Scholar 

  14. Hunt LP, Ben-Shlomo Y, Clark EM, Dieppe P, Judge A, MacGregor AJ, Tobias JH, Vernon K, Blom AW (2013) 90-day mortality after 409 096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis. The Lancet 382(9898):1097–1104

    Article  Google Scholar 

  15. White S, Moppett I, Griffiths R (2014) Outcome by mode of anaesthesia for hip fracture surgery. An observational audit of 65 535 patients in a national dataset. Anaesthesia 69(3):224–230

    Article  CAS  PubMed  Google Scholar 

  16. Halawi MJ, Plourde J, Cote MP (2019a) Response to letter to the editor on “Routine postoperative laboratory tests are not necessary after primary total hip arthroplasty.” J Arthroplasty 34(5):1045

    Article  PubMed  Google Scholar 

  17. Wu X-D, Jiang F, Xiang B-Y, Huang W (2019) Letter to the editor on “Routine postoperative laboratory tests are not necessary after primary total hip arthroplasty.” J Arthroplasty 34(5):1043–1045

    Article  PubMed  Google Scholar 

  18. Le Manach Y, Collins G, Bhandari M, Bessissow A, Boddaert J, Khiami F, Chaudhry H, De Beer J, Riou B, Landais P (2015) Outcomes after hip fracture surgery compared with elective total hip replacement. JAMA 314(11):1159–1166

    Article  PubMed  CAS  Google Scholar 

  19. Cook A, Cook S, Smith I (2014) Weinrauch P (2014) Hip resurfacing arthroplasty and perioperative blood testing. Adv Orthop 2014:109378

    Article  PubMed  PubMed Central  Google Scholar 

  20. Jagow DM, Yacoubian SV, Yacoubian SV (2015) Complete blood count before and after total hip or knee arthroplasty. J Orthop Surg (Hong Kong) 23(2):209–212

    Article  Google Scholar 

  21. Shaner JL, Karim AR, Casper DS, Ball CJ, Padegimas EM, Lonner JH (2016) Routine postoperative laboratory tests are unnecessary after partial knee arthroplasty. J Arthroplasty 31(12):2764–2767

    Article  PubMed  Google Scholar 

  22. Kildow BJ, Karas V, Howell E, Green CL, Baumgartner WT, Penrose CT, Bolognesi MP, Seyler TM (2018) The utility of basic metabolic panel tests after total joint arthroplasty. J Arthroplasty 33(9):2752–2758

    Article  PubMed  Google Scholar 

  23. Halawi MJ, Lyall V, Cote MP (2020) Re-evaluating the utility of routine postoperative laboratory tests after primary total knee arthroplasty. J Clin Orthop Trauma 11:S219–S222

    Article  PubMed  Google Scholar 

  24. Halawi MJ, Plourde JM, Cote MP (2019b) Routine postoperative laboratory tests are not necessary after primary total hip arthroplasty. J Arthroplasty 34(3):538–541

    Article  PubMed  Google Scholar 

  25. Howell EP, Kildow BJ, Karas V, Green CL, Cunningham DJ, Ryan SP, Bolognesi MP, Seyler TM (2019) Clinical impact of routine complete blood counts following total knee arthroplasty. J Arthroplasty 34(7):S168–S172

    Article  PubMed  Google Scholar 

  26. Greco N, Manocchio A, Lombardi A, Gao S, Adams J, Berend K (2019) Should postoperative haemoglobin and potassium levels be checked routinely following blood-conserving primary total joint arthroplasty? Bone Joint J 101(1_Supple_A):25–31

    Article  PubMed  Google Scholar 

  27. Wu XD, Zhu ZL, Xiao PC, Liu JC, Wang JW, Huang W (2020) Are routine postoperative laboratory tests necessary after primary total hip arthroplasty? J Arthroplasty. 35:2892–2898

    Article  PubMed  Google Scholar 

  28. Wu X-D, Xiao P-C, Zhu Z-L, Liu J-C, Li Y-J, Huang W (2019) The necessity of routine postoperative laboratory tests in enhanced recovery after surgery for primary hip and knee arthroplasty: a retrospective cohort study protocol. Medicine 98:18

    Google Scholar 

  29. World Health Organization (2011). Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. World Health Organization https://apps.who.int/iris/handle/10665/85839.

  30. Gatta A, Verardo A, Bolognesi M (2012) Hypoalbuminemia. Intern Emerg Med 7(Suppl 3):S193–S199

    Article  PubMed  Google Scholar 

  31. Zhang J, Zhang R, Wang Y, Li H, Han Q, Wu Y, Wang T, Liu F (2019) The level of serum albumin is associated with renal prognosis in patients with diabetic nephropathy. J Diabetes Res 2019:7825804

    PubMed  PubMed Central  Google Scholar 

  32. Metcalfe D, Perry DC, Costa ML (2016) Hip fracture surgery vs elective total hip replacement. JAMA 315(9):941–942

    Article  PubMed  Google Scholar 

  33. Grace TR, Patterson JT, Tangtiphaiboontana J, Krogue JD, Vail TP, Ward DT (2018) Hip fractures and the bundle: a cost analysis of patients undergoing hip arthroplasty for femoral neck fracture vs degenerative joint disease. J Arthroplasty 33(6):1681–1685

    Article  PubMed  Google Scholar 

  34. Wu VJ, Ross B, Sanchez FL, Billings CR, Sherman WF (2020) Complications following total hip arthroplasty: a nationwide database comparing elective vs. Hip Fracture Cases. J Arthroplasty. 35(8):2144–2148

    Article  PubMed  Google Scholar 

  35. Van Citters AD, Fahlman C, Goldmann DA, Lieberman JR, Koenig KM, DiGioia AM, O’Donnell B, Martin J, Federico FA, Bankowitz RA (2014) Developing a pathway for high-value, patient-centered total joint arthroplasty. Clin Orthop Relat Res 472(5):1619–1635

    Article  PubMed  Google Scholar 

  36. Desborough J (2000) The stress response to trauma and surgery. Br J Anaesth 85(1):109–117

    Article  CAS  PubMed  Google Scholar 

  37. Simunovic N, Devereaux P, Sprague S, Guyatt GH, Schemitsch E, DeBeer J, Bhandari M (2010) Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis. CMAJ 182(15):1609–1616

    Article  PubMed  PubMed Central  Google Scholar 

  38. Bohl DD, Ondeck NT, Darrith B, Hannon CP, Fillingham YA, Della Valle CJ (2018) Impact of operative time on adverse events following primary total joint arthroplasty. J Arthroplasty 33(7):2256–2262

    Article  PubMed  Google Scholar 

  39. Wu X-D, Hu K-J, Tian M, Huang W (2018) Letter to the editor on “impact of operative time on adverse events following primary total joint arthroplasty.” J Arthroplasty 33(8):2701–2702

    Article  PubMed  Google Scholar 

  40. Anis HK, Sodhi N, Klika AK, Mont MA, Barsoum WK, Higuera CA, Molloy RM (2019) Is operative time a predictor for post-operative infection in primary total knee arthroplasty? J Arthroplasty 34(7):S331–S336

    Article  PubMed  Google Scholar 

  41. Willis-Owen C, Konyves A, Martin D (2010) Factors affecting the incidence of infection in hip and knee replacement: an analysis of 5277 cases. J Bone Joint Surg Br 92(8):1128–1133

    Article  CAS  PubMed  Google Scholar 

  42. Helm A, Karski M, Parsons S, Sampath J, Bale R (2003) A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery: audit of an algorithm for arthroplasty of the lower limb. J Bone Joint Surg Br 85(4):484–489

    Article  CAS  PubMed  Google Scholar 

  43. Ralley FE, Berta D, Binns V, Howard J, Naudie DD (2010) One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res 468(7):1905–1911

    Article  PubMed  PubMed Central  Google Scholar 

  44. Friedman R, Homering M, Holberg G, Berkowitz SD (2014) Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am 96(4):272–278

    Article  PubMed  Google Scholar 

  45. Bedard NA, Pugely AJ, Lux NR, Liu SS, Gao Y, Callaghan JJ (2017) Recent trends in blood utilization after primary hip and knee arthroplasty. J Arthroplasty 32(3):724–727

    Article  PubMed  Google Scholar 

  46. Lindman IS, Carlsson LV (2018) Extremely low transfusion rates: contemporary primary total hip and knee arthroplasties. J Arthroplasty 33(1):51–54

    Article  PubMed  Google Scholar 

  47. Wu X-D, Tian M, He Y, Chen Y, Tao Y-Z, Shao L, Luo C, Xiao P-C, Zhu Z-L, Liu J-C (2020) Efficacy of a three-day prolonged-course of multiple-dose versus a single-dose of tranexamic acid in total hip and knee arthroplasty. Ann Transl Med 8:6

    Article  CAS  Google Scholar 

  48. Bistrian BR, Blackburn GL, Hallowell E, Heddle R (1974) Protein status of general surgical patients. JAMA 230(6):858–860

    Article  CAS  PubMed  Google Scholar 

  49. Huang R, Greenky M, Kerr GJ, Austin MS, Parvizi J (2013) The effect of malnutrition on patients undergoing elective joint arthroplasty. J Arthroplasty 28(8):21–24

    Article  PubMed  Google Scholar 

  50. Walls JD, Abraham D, Nelson CL, Kamath AF, Elkassabany NM, Liu J (2015) Hypoalbuminemia more than morbid obesity is an independent predictor of complications after total hip arthroplasty. J Arthroplasty 30(12):2290–2295

    Article  PubMed  Google Scholar 

  51. Paul HY, Frank RM, Vann E, Sonn KA, Moric M, Della Valle CJ (2015) Is potential malnutrition associated with septic failure and acute infection after revision total joint arthroplasty? Clin Orthop Relat Res 473(1):175–182

    Article  Google Scholar 

  52. Sloan M, Sheth NP, Nelson CL (2020) Obesity and hypoalbuminaemia are independent risk factors for readmission and reoperation following primary total knee arthroplasty. Bone Joint J 102-B(6_Supple_A):31–35

    Article  PubMed  Google Scholar 

  53. Cao G, Huang Q, Xu B, Huang Z, Xie J, Pei F (2017) Multimodal nutritional management in primary total knee arthroplasty: a randomized controlled trial. J Arthroplasty 32(11):3390–3395

    Article  PubMed  Google Scholar 

  54. Liu M, Yang J, Yu X, Huang X, Vaidya S, Huang F, Xiang Z (2015) The role of perioperative oral nutritional supplementation in elderly patients after hip surgery. Clin Interv Aging 10:849

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Nowicka A, Selvaraj T (2016) Incidence of acute kidney injury after elective lower limb arthroplasty. J Clin Anesth 34:520–523

    Article  PubMed  Google Scholar 

  56. Perregaard H, Damholt MB, Solgaard S, Petersen MB (2016) Renal function after elective total hip replacement: Incidence of acute kidney injury and prevalence of chronic kidney disease. Acta Orthop 87(3):235–238

    Article  PubMed  PubMed Central  Google Scholar 

  57. Gai P, Sun H, Sui L, Wang G (2016) Hypocalcaemia after total knee arthroplasty and its clinical significance. Anticancer Res 36(3):1309–1311

    CAS  PubMed  Google Scholar 

  58. Anastasio AT, Farley KX, Boden SD, Bradbury TL, Premkumar A, Gottschalk MB (2020) Modifiable, Postoperative Risk Factors for Delayed Discharge Following Total Knee Arthroplasty: The Influence of Hypotension and Opioid Use. J Arthroplasty 35(1):82–88

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Zheng-Lin Zhu, M.D., Ph.D., and Peng-Cheng Xiao, M.D. (From the Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China) for their substantial contribution to the acquisition of data for this work.

Funding

This study was supported by the Special Fund for Local Scientific and Technological Development under the Guidance of the Central Government (grant no. Z135050009017).

Author information

Author notes

  1. Xiang-Dong Wu, Jia-Cheng Liu, and Yu-Jian Li contributed equally to this work

Authors and Affiliations

  1. Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, No. 1, Youyi Road, Yuanjiagang, Yuzhong District, Chongqing, 400016, China

    Xiang-Dong Wu, Jia-Cheng Liu, Yu-Jian Li, Jia-Wei Wang & Wei Huang

  2. Department of Orthopaedic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China

    Xiang-Dong Wu & Gui-Xing Qiu

Authors
  1. Xiang-Dong Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jia-Cheng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu-Jian Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jia-Wei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gui-Xing Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wei Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

X.-D.W. contributed substantially to conception and design, acquisition of data, analysis, and interpretation of data; drafted the article; gave final approval of the version to be published; agreed to act as a guarantor of the work. J.-C.L. contributed substantially to the acquisition and interpretation of data, revised it critically for valuable intellectual content, gave final approval of the version to be published, and agreed to act as a guarantor of the work. Y.-J.L. contributed substantially to the acquisition and interpretation of data, revised it critically for valuable intellectual content, gave final approval of the version to be published, and agreed to act as a guarantor of the work. J.-W.W. contributed substantially to the acquisition and interpretation of data, revised it critically for valuable intellectual content, gave final approval of the version to be published, and agreed to act as a guarantor of the work. G.-X.Q. contributed substantially to the conception and design, acquisition of data, analysis, and interpretation of data, revised it critically for valuable intellectual content, gave final approval of the version to be published, and agreed to act as a guarantor of the work. W.H. contributed substantially to the conception and design, acquisition of data, analysis, and interpretation of data, revised it critically for valuable intellectual content, gave final approval of the version to be published, and agreed to act as a guarantor of the work. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Wei Huang.

Ethics declarations

Ethics approval and consent to participate

Ethical approval (IRB 2019-015) for this study was obtained from the Ethics Committee of The First Affiliated Hospital of Chongqing Medical University. Clinical Trial Registry number: ChiCTR1900020690. Available at: https://www.chictr.org.cn/hshowproject.aspx?id=14458

Consent for publication

Not applicable.

Conflict of interests

The authors have declared no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1: Material S1.

Reference ranges for complete blood count and comprehensive metabolic panel and corresponding threshold values for clinical intervention.

Additional file 2: Material S2.

The necessity of routine postoperative laboratory tests for enhanced recovery after surgery for primary hip and knee arthroplasty.

Additional file 3: Material S3.

IRB approval.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, XD., Liu, JC., Li, YJ. et al. The necessity of routine postoperative laboratory tests after total hip arthroplasty for hip fracture in a semi-urgent clinical setting. J Orthop Traumatol 21, 19 (2020). https://doi.org/10.1186/s10195-020-00559-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s10195-020-00559-3

Keywords